Research Spotlight
Comprehensive Cancer Centers has affiliated with one of the world’s most 
recognizable research and cancer-fighting organizations, Sarah Cannon Research Institute (SCRI), to offer groundbreaking research to its patients. The practice participates in more than 120 Phase I, Phase II and Phase III clinical research studies each year and has played a role in developing more than 100 FDA-approved cancer therapies.
The practice, in collaboration with KSNV News 3 Las Vegas, is showcasing patients who have had amazing results from participating in clinical research. Click on the links below to learn more about these patients and their cancer journey.
